Study details
Enrolling now
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
Vanderbilt University Medical Center
NCT IDNCT05422534ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
156
Study length
about 4.3 years
Ages
18–75
Locations
2 sites in CA, TN
About this study
This trial is testing whether CoQ10, combined with high-intensity interval training (HIIT), can improve mitochondrial function in people with advanced kidney disease. The goal is to see if this combination helps prevent frailty, sarcopenia, and muscle dysfunction.
Based on ClinicalTrials.gov records.
What participants do
- 1.CoQ10
- 2.Participate in HB-HIIT
- 3.Participate in Observational
- +1 more
PhasePhase 3
DrugCoQ10
Primary goalPCr recovery measured by 31 phosphorus magnetic resonance spectroscopy
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low15%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ubidecarenone
Endpoints
Primary: PCr recovery measured by 31 phosphorus magnetic resonance spectroscopy
Secondary: Six minute walk test
Body systems
Renal